QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Azzi, A. Articles by Zingg, J.-M. Search for Related Content PubMed PubMed Citation Articles by Azzi, A. Articles by Zingg, J.-M.

---

Supplement

Nonantioxidant Functions of -Tocopherol in Smooth Muscle Cells^{1 ,2}

Institute of Biochemistry and Molecular Biology, 3012 Bern, Switzerland

³To whom correspondence should be addressed. E-mail: angelo.azzi{at}mci.unibe.ch.

Most tocopherols and tocotrienols, with the exception of -tocopherol, are not retained by humans. This suggests that -tocopherol is recognized uniquely; therefore, it may exert an exclusive function. -Tocopherol possesses distinct properties that are independent of its prooxidant, antioxidant or radical-scavenging ability. -Tocopherol specifically inhibits protein kinase C, the growth of certain cells and the transcription of the CD36 and collagenase genes. Activation events have also been seen on the protein phosphatase 2A (PP₂A) and on the expression of other genes (-tropomyosin and connective tissue growth factor). Neither ß-tocopherol nor probucol possessed the same specialty functions as -tocopherol. Recently, we isolated a new ubiquitous cytosolic -tocopherol binding protein (TAP). Its motifs suggest that it is a member of the hydrophobic ligand-binding protein family (CRAL-TRIO). TAP may also be involved in the regulation of cellular -tocopherol concentration and -tocopherol–mediated signaling.

KEY WORDS: • tocotrienols • tocopherols • cell signaling • -tocopherol binding protein

This article has been cited by other articles:

				R. Siekmeier, C. Steffen, and W. Marz Role of Oxidants and Antioxidants in Atherosclerosis: Results of In Vitro and In Vivo Investigations Journal of Cardiovascular Pharmacology and Therapeutics, December 1, 2007; 12(4): 265 - 282. [Abstract] [PDF]

				I. Kolleck, P. Sinha, and B. Rustow Vitamin E as an Antioxidant of the Lung: Mechanisms of Vitamin E Delivery to Alveolar Type II Cells Am. J. Respir. Crit. Care Med., December 15, 2002; 166(12): S62 - 66. [Abstract] [Full Text] [PDF]

				R. Gopalakrishna and U. Gundimeda Antioxidant Regulation of Protein Kinase C in Cancer Prevention J. Nutr., December 1, 2002; 132(12): 3819S - 3823. [Abstract] [Full Text] [PDF]

				H. N. Hodis, W. J. Mack, L. LaBree, P. R. Mahrer, A. Sevanian, C.-r. Liu, C.-h. Liu, J. Hwang, R. H. Selzer, S. P. Azen, et al. Alpha-Tocopherol Supplementation in Healthy Individuals Reduces Low-Density Lipoprotein Oxidation but Not Atherosclerosis: The Vitamin E Atherosclerosis Prevention Study (VEAPS) Circulation, September 17, 2002; 106(12): 1453 - 1459. [Abstract] [Full Text] [PDF]

				A. A. Qureshi, W. A. Salser, R. Parmar, and E. E. Emeson Novel Tocotrienols of Rice Bran Inhibit Atherosclerotic Lesions in C57BL/6 ApoE-Deficient Mice J. Nutr., October 1, 2001; 131(10): 2606 - 2618. [Abstract] [Full Text] [PDF]